TRUIST FINANCIAL CORP - CARDIFF ONCOLOGY INC ownership

CARDIFF ONCOLOGY INC's ticker is CRDF and the CUSIP is 14147L108. A total of 87 filers reported holding CARDIFF ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.51 and the average weighting 0.5%.

Quarter-by-quarter ownership
TRUIST FINANCIAL CORP ownership history of CARDIFF ONCOLOGY INC
ValueSharesWeighting
Q4 2021$769,000
-28.0%
127,985
-20.2%
0.00%
-50.0%
Q3 2021$1,068,0000.0%160,400
-0.1%
0.00%0.0%
Q2 2021$1,068,000
-3.4%
160,492
+34.4%
0.00%0.0%
Q1 2021$1,106,000
-46.5%
119,400
+3.8%
0.00%
-50.0%
Q4 2020$2,069,000115,0000.00%
Other shareholders
CARDIFF ONCOLOGY INC shareholders Q4 2020
NameSharesValueWeighting ↓
CAXTON CORP 2,522,083$15,158,00012.39%
Octagon Capital Advisors LP 982,753$5,906,0001.15%
Altium Capital Management LP 337,000$2,025,0000.56%
ACT CAPITAL MANAGEMENT, LLC 102,500$616,0000.44%
Eventide Asset Management 1,670,399$10,039,0000.13%
Artal Group S.A. 750,000$4,508,0000.12%
Aquatic Capital Management LLC 8,000$48,0000.09%
ELKHORN PARTNERS LIMITED PARTNERSHIP 17,300$104,0000.06%
Anson Funds Management LP 69,381$417,0000.04%
KENNEDY CAPITAL MANAGEMENT LLC 170,447$1,024,0000.02%
View complete list of CARDIFF ONCOLOGY INC shareholders